RxDoctor Payments Data

Eric Barp

Podiatrist · West Des Moines, IANPI 1467445064

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (39.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Ortho Solutions Inc at 35.7% of the total. Among podiatrist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$149,480in general payments, 2019–2025

Across 224 payments — averaging $667.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho Solutions Inc$53K
  • Stryker$49K
  • Smith+Nephew$24K
  • Zimmer Biomet$15K
  • Bone Support Inc.$3K
  • Organogenesis Inc.$3K
  • plus $3K from 14 others
$20,000in research payments, 2019–2025

Across 1 payment — averaging $20,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$20K

What the payments were for

  • Royalty or licence$58,33339%
  • Consulting fees$57,22838%
  • Speaking & faculty fees$14,99110%
  • Travel & lodging$8,0855%
  • Food & beverage$6,6724%
  • Education$4,1703%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$149,480 in reported general payments places this provider in the 95th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$142,338
Medicare patients
458
Services billed
3,079

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox41$1,313
Meloxicam369$621
Gabapentin83$486
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen50$465
Methylprednisolone43$262
Diclofenac Sodium16$193
Tramadol Hcl16$44

Paid to pharmacies, not to this prescriber.

Other podiatrist in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →